Serum concentration of taurochenodeoxycholic acid predicts clinically significant portal hypertension

Abstract

TCDCA seems to be a promising noninvasive marker of clinically significant portal hypertension. Its predictive potential may be further enhanced when it is combined with both the AST/ALT ratio and spleen diameter.